Overview
Based on the genotype characteristics and genotype-phenotype-treatment prognosis data of Chinese WD patients, this study intends to further optimize the treatment regimen of Chinese WD patients and formulate individualized treatment regimens for each genotype, so as to further improve the prognosis of patients.
Description
The purpose of the study is to evaluate treatment regimen efficacy based on different mutations, and Zinc treatment in presymptomatic WD patients.
Eligibility
Inclusion Criteria:
- Genetic diagnosis of Wilson's disease
- Presymptomatic patients with Wilson's disease
Exclusion Criteria:
- Movement disorder due to other definite causes instead of Wilson's disease
- Severe Lung, kidney or liver disease
- Neoplastic Disease